Perivalvular sealing for transcatheter heart valve

US11278400B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11278400-B2
Application numberUS-201916553003-A
CountryUS
Kind codeB2
Filing dateAug 27, 2019
Priority dateJul 15, 2011
Publication dateMar 22, 2022
Grant dateMar 22, 2022

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A prosthetic heart valve includes a frame, a valvular structure coupled to the frame, and a sealing member coupled to the frame. The frame has inflow and outflow ends and a lumen extending therebetween. The frame includes struts that form cells, and the cells are arranged in three rows. The frame is radially expandable from a collapsed state to an expanded state. The valvular structure includes a plurality of leaflets configured to allow blood flow through the lumen of the frame from the inflow end to the outflow end and to block blood flow through the lumen of the frame from the outflow end to the inflow end. The sealing skirt extends from an intermediate location of the frame disposed between the inflow and outflow ends to the inflow end of the frame. The sealing skirt covers two rows of cells to block blood flow through the cells.

First claim

Opening claim text (preview).

We claim: 1. A balloon-expandable prosthetic heart valve comprising: an annular frame having an inflow end, an outflow end, and a lumen extending from the inflow end to the outflow end along a central longitudinal axis of the frame, wherein the frame includes a plurality of struts that form cells, wherein the cells are arranged in exactly three rows of cells, and wherein the frame is radially expandable from a collapsed state to an expanded state; a valvular structure coupled to the frame, wherein the valvular structure includes a plurality of leaflets configured to allow blood flow through the lumen of the frame from the inflow end to the outflow end and to block blood flow through the lumen of the frame from the outflow end to the inflow end; and a sealing skirt coupled to the frame, wherein the sealing skirt extends from an intermediate location of the frame disposed between the inflow end and the outflow end of the frame, wherein the lower end portion of the sealing skirt is disposed adjacent to the inflow end of the frame, wherein the sealing skirt is axially movable relative to the central longitudinal axis of the frame when the frame moves radially from the collapsed state to the expanded state, and wherein the sealing skirt covers two rows of cells when the frame is in the expanded state. 2. The prosthetic heart valve of claim 1 , wherein the two rows of cells covered by the sealing skirt include a first row of cells disposed adjacent the inflow end of the frame and a second row of cells disposed adjacent the first row of cells and toward the outflow end of the frame relative to the first row of cells. 3. The prosthetic heart valve of claim 1 , wherein the sealing skirt does not cover a third row of cells. 4. The prosthetic heart valve of claim 1 , wherein each leaflet has a scalloped edge portion that is secured to the sealing skirt by sutures. 5. The prosthetic heart valve of claim 1 , wherein the sealing skirt is disposed on a radially inwardly facing side of the frame. 6. The prosthetic heart valve of claim 1 , wherein the sealing skirt comprises polyethylene terephthalate or ultra-high molecular weight polyethylene. 7. The prosthetic heart valve of claim 1 , wherein the frame comprises a nickel-cobalt-chromium alloy. 8. The prosthetic heart valve of claim 1 , wherein the cells are hexagonal cells, wherein each of the hexagonal cells is defined by six struts, including: two opposing side struts extending parallel to each other, a first pair of angled struts extending from respective first ends of the side struts and converging to intersect with each other, wherein an intersection of the first pair of angled struts is directed toward the inflow end of the frame, and a second pair of angled struts extending from respective second ends of the side struts and converging to intersect with each other, wherein an intersection of the second pair of angled struts is directed toward the outflow end of the frame. 9. The prosthetic heart valve of claim 1 , wherein the frame is made of a plastically-expandable material comprising stainless steel or a nickel-based alloy. 10. The prosthetic heart valve of claim 1 , wherein the sealing skirt is positioned on an outer side of the frame. 11. The prosthetic heart valve of claim 1 , wherein the sealing skirt is a first sealing skirt disposed on an outer side of the frame, and wherein the prosthetic heart valve further comprises a second sealing skirt disposed on an inner side of the frame. 12. A balloon-expandable prosthetic heart valve comprising: a frame having a ventricular end, an aortic end, and a lumen extending from the ventricular end to the aortic end, wherein the frame includes a plurality of struts that form hexagonal cells, wherein the hexagonal cells are arranged in exactly three rows of hexagonal cells, and wherein the frame is radially expandable from a radially collapsed state to a radially expanded state; a leaflet structure coupled to the frame, wherein the leaflet structure includes exactly three leaflets configured to allow blood flow in a first direction through the lumen of the frame and to block blood flow in a second direction through the lumen of the frame, and wherein the first direction is opposite the first direction; and a sealing member positioned on the outside of the frame and comprising a first end portion and a second end portion, wherein the first end portion of the sealing member is tethered to the frame via a suture material at a location between the ventricular end and the aortic end of the frame, wherein the second end portion of the sealing member is untethered to the frame and disposed adjacent the ventricular end of the frame when the frame is in the radially expanded state, thereby allowing the sealing member to move axially relative to a longitudinal axis of the frame when the frame moves from the radially collapsed state to the radially expanded state, wherein the sealing member at least substantially covers a first row of hexagonal cells and a second row of hexagonal cells when the frame is in the radially expanded state, wherein the first row of hexagonal cells is disposed adjacent the ventricular end of the frame, and wherein the second row of hexagonal cells is disposed adjacent the first row of hexagonal cells and toward the aortic end of the frame relative to the first row of hexagonal cells. 13. The prosthetic heart valve of claim 12 , wherein the sealing member is a fabric skirt. 14. The prosthetic heart valve of claim 13 , wherein the sealing member comprises polyethylene terephthalate or ultra-high molecular weight polyethylene. 15. The prosthetic heart valve of claim 14 , wherein the frame comprises a nickel-cobalt-chromium-molybdenum alloy. 16. The prosthetic heart valve of claim 12 , wherein the sealing member protrudes radially outwardly relative to the frame. 17. The prosthetic heart valve of claim 12 , wherein the sealing member includes a first portion disposed on an inside of the frame and a plurality of flaps disposed on the outside of the frame, wherein the flaps are configured to expand radially outwardly relative to the frame and contact native tissue to help seal any gaps between the prosthetic heart valve and the native tissue. 18. The prosthetic heart valve of claim 12 , wherein the sealing member does not cover a third row of cells. 19. A balloon-expandable prosthetic heart valve comprising: a frame having a first end, a second end, and a plurality of struts defining closed cells, wherein the closed cells are arranged in three circumferentially-extending rows of closed cells, wherein the frame is radially expandable from a collapsed state to an expanded state, wherein the frame axially foreshortens along a longitudinal axis when the frame moves radially from the collapsed state to the expanded state, and wherein the frame comprises a nickel-cobalt-chromium alloy; a leaflet structure coupled to the frame, wherein the leaflet structure includes a plurality of leaflets configured to allow blood flow through the prosthetic heart valve in an antegrade direction and to block blood flow through the prosthetic heart valve in a retrograde direction; and a sealing member coupled to the frame via a suture material, wherein the sealing member is configured to move axially relative to the longitudinal axis of the frame when the frame moves from the radially collapsed state to the radially expanded state, wherein when the frame is in the expanded state, the sealing member completely covers a first row of closed cells of the frame and a second

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11278400B2 cover?
A prosthetic heart valve includes a frame, a valvular structure coupled to the frame, and a sealing member coupled to the frame. The frame has inflow and outflow ends and a lumen extending therebetween. The frame includes struts that form cells, and the cells are arranged in three rows. The frame is radially expandable from a collapsed state to an expanded state. The valvular structure includes…
Who is the assignee on this patent?
Edwards Lifesciences Corp
What technology area does this patent fall under?
Primary CPC classification A61F2/2418. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Mar 22 2022 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 6 related publications on this page (citations in our corpus or others sharing the same primary CPC).